Paradigm Medical Enters into Exclusive Discussions with Leading Chinese Engineering Firm for Development and Production of Ultrasound and Medical Products.SALT LAKE CITY -- Paradigm Medical Industries, Inc. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). : PMED PMED Primary and Mass Education Division .OB/PMEDW.OB), a leading innovative producer of ultrasound devices for the ophthalmic and medical industries, today announced it has entered into exclusive discussions with a leading Chinese medical engineering and research firm aimed at developing Paradigm's next generation of ultrasound products for the medical industry. Terms were not disclosed. "We believe a potential collaboration with the Chinese firm's engineers and medical academicians will result in increased functionality and state-of-the-art ultrasound devices," said Paradigm Medical's President and Chief Executive Officer, Raymond Cannefax. "The Chinese firm and Paradigm Medical would jointly provide hardware and software engineering input based on the latest technological developments in order to develop products that will meet the needs of medical professionals using these ultrasound devices." In addition to broadening its ophthalmic product line, the Company is expanding some of its ultrasound products into the veterinary industry. "There is a continual increase in veterinary ophthalmology ophthalmology (ŏf'thălmŏl`əjē), branch of medicine specializing in the anatomy, function and diseases of the eye. Ophthalmologists specialize in the medical and surgical treatment of eye disorders, vision measurements for , and we believe we can share in the growth and further enhance that market opportunity," Mr. Cannefax added. "The Chinese firm's engineering, research, and production skills should also help dramatically in reducing our research and engineering expenditures. Our revitalized global sales and marketing organization is making significant efforts to enable the Company to maximize this opportunity," Mr. Cannefax added. Paradigm Medical and the Chinese firm's executives will be meeting during the week of the 21st Congress of the Asian Pacific Academy of Ophthalmology (APAO APAO Asia Pacific Academy of Ophthalmology APAO Aggregate Producers' Association of Ontario (Canada) APAO Asphalt Pavement Association of Oregon (Salem, Oregon) APAO amorphous polyalphaolefin ) meeting, held this June in Singapore. New engineering concepts will be implemented into a newly designed 50 MHz (MegaHertZ) One million cycles per second. It is used to measure the transmission speed of electronic devices, including channels, buses and the computer's internal clock. A one-megahertz clock (1 MHz) means some number of bits (16, 32, 64, etc. specific Ultrasound BioMicroscope (UBM UBM United Business Media Plc (London) UBM Under-Bump Metallization UBM UniCredit Banca Mobiliare S.p.A. (Italy) UBM United Bikers of Maine UBM Unbalanced Magnetron UBM Ultimate Building Machine ). Glaucoma glaucoma (glôkō`mə), ocular disorder characterized by pressure within the eyeball caused by an excessive amount of aqueous humor (the fluid substance filling the eyeball). and refractive refractive capacity to refract light. refractive error a difference between the focal length of the cornea and lens, and the length of the eye, resulting in myopia or hyperopia. ophthalmic experts attending APAO Congress will be able to provide valuable input to confirm the results are in line with their expectations. Paradigm Medical Industries, Inc. (Salt Lake City, UT), currently develops, manufactures and markets high-tech, proprietary diagnostic equipment and consumable products for the medical industry. The Company is a leading developer of Ultrasound devices, and has been dubbed "The UBM Company" (Ultrasound BioMicroscope). Contact us at 801- 977-8970 or visit us at www.paradigm-medical.com. This press release contains statements that, if not verifiable historic fact, may be viewed as forward-looking statements that could predict future events and outcomes with respect to Paradigm and its business. The predictions embodied in these statements will involve risk and uncertainties and, accordingly, actual results may differ significantly from the results discussed or implied in such forward-looking statements. |
|
||||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion